QIA (QIA)
0.00
-10.35 (100.00%)
Latest Headlines
QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak
July 15, 2026 4:05 PM - BizWire
QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast
July 15, 2026 8:48 AM - BizWire
QIAGEN Expands QIAstat-Dx Bloodstream Infection Testing Menu in Europe
July 14, 2026 4:05 PM - BizWire
QIAGEN Expands QIAcuity Gene Expression Portfolio to Accelerate Digital PCR Adoption Across Research and Biopharma
June 15, 2026 1:30 AM - BizWire
QIAGEN releases digital PCR assays for Bundibugyo ebolavirus research
May 28, 2026 4:06 PM - StreetInsider
QIAGEN Supports Infectious Disease Research and Surveillance Efforts for Bundibugyo Ebolavirus Outbreak
May 28, 2026 4:05 PM - BizWire
QIAGEN launches QIA Agent, connecting AI-driven scientific guidance across Sample to Insight workflows
May 20, 2026 4:05 PM - BizWire
QIAGEN to advance AI-driven drug discovery with graph-based AI and curated bioinformatics knowledge with NVIDIA
May 19, 2026 4:05 PM - BizWire
QIAGEN to Appoint Dr. Metin Colpan as Honorary Chairman of the Supervisory Board, Continue Governance Renewal and Propose Increased Returns at 2026 Annual General Meeting
May 12, 2026 2:00 AM - BizWire
QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing
May 7, 2026 6:00 AM - BizWire
QIAGEN Reports Full Results for Q1 2026
May 6, 2026 4:05 PM - BizWire
QIAGEN lowers 2026 outlook as QuantiFERON immigration testing drops
April 27, 2026 4:16 PM - StreetInsider
QIAGEN reports preliminary Q1 2026 results: achieves adjusted EPS outlook with mixed sales trends; updates full-year 2026 outlook
April 27, 2026 4:16 PM - BizWire
Full Article List
